Le produit a bien été ajouté au panier.

discount label
H-HLNILSTLWKYR-NH2
Vue en 3D

Biosynth logo

H-HLNILSTLWKYR-NH2

Ref. 3D-PP46163

Taille indéfinieÀ demander
Livraison estimée en/au États-Unis, le mardi 10 décembre 2024

Informations sur le produit

Nom :
H-HLNILSTLWKYR-NH2
Synonymes :
  • NH2-His-Leu-Asn-Ile-Leu-Ser-Thr-Leu-Trp-Lys-Tyr-Arg-amide
Description :

Peptide H-HLNILSTLWKYR-NH2 is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-HLNILSTLWKYR-NH2 include the following: Targeted delivery of Tet1 peptide functionalized polymersomes to the rat cochlear nerve Y Zhang, W Zhang, AH Johnston - International journal , 2012 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.2147/IJN.S28185 Applications of Nanoparticles in Alzheimer's Disease Y Liu, Y Shen - Journal of Alzheimer's Disease, 2023 - content.iospress.comhttps://content.iospress.com/articles/journal-of-alzheimers-disease/jad230098 Tet1 peptide and zinc (II)-adenine multifunctional module functionalized polycations as efficient siRNA carriers for Parkinson's disease W Liu, C Ma, J Cao, H Zhou, T Guo - Journal of Controlled Release, 2024 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0168365924000579 A means for targeting therapeutics to peripheral nervous system neurons with axonal damage T Federici, JK Liu , Q Teng, J Yang, NM Boulis - Neurosurgery, 2007 - journals.lww.comhttps://journals.lww.com/neurosurgery/fulltext/2007/05000/Bovine_Pericardium_for_Dural_Grafts__Clinical.15.aspx Non-viral carriers for nucleic acids delivery: Fundamentals and current applications S Shtykalova , D Deviatkin, S Freund, A Egorova - Life, 2023 - mdpi.comhttps://www.mdpi.com/2075-1729/13/4/903 "œCascaded Rocket" Nanosystems with Spatiotemporal Separation for Triple-Synergistic Therapy of Alzheimer's Disease R Liu , J Yang, X Qiu, W Ji, J Shen, Y Li - Advanced , 2022 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/adhm.202101748 Poly-Lactide/Poly-Lactide-co-Glycolide-Based Delivery System for Bioactive Compounds against Microbes R Kumar , D Jha , AK Panda - Pharmaceuticals from Microbes: The , 2019 - Springerhttps://link.springer.com/chapter/10.1007/978-3-030-01881-8_3 Diagnostic and therapeutic potential of tetanus toxin-derivatives in neurological diseases R Kassa, V Monterroso, LL David - Journal of Molecular , 2013 - Springerhttps://link.springer.com/article/10.1007/s12031-013-0065-x Development of peptide targeted PLGA-PEGylated nanoparticles loading licochalcone-A for ocular inflammation R Galindo, E Sanchez-Lopez, MJ Gomara, M Espina - Pharmaceutics, 2022 - mdpi.comhttps://www.mdpi.com/1999-4923/14/2/285 Development of surface-engineered PLGA nanoparticulate-delivery system of Tet1-conjugated nattokinase enzyme for inhibition of Abeta40 plaques in Alzheimer's PC Bhatt, A Verma , FA Al-Abbasi , F Anwar - International journal , 2017 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.2147/IJN.S144545 Systemic delivery of BACE1 siRNA through neuron-targeted nanocomplexes for treatment of Alzheimer's disease P Wang, X Zheng, Q Guo, P Yang, X Pang - Journal of controlled , 2018 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0168365918302190 Therapeutic and diagnostic applications of nanocomposites in the treatment Alzheimer's disease studies M Pathak , R Singhal - Biointerface Research in Applied , 2022 - biointerfaceresearch.comhttps://biointerfaceresearch.com/wp-content/uploads/2021/04/20695837121.940960.pdf Polymeric nanoparticles properties and brain delivery L Ribovski , NM Hamelmann , JMJ Paulusse - Pharmaceutics, 2021 - mdpi.comhttps://www.mdpi.com/1999-4923/13/12/2045 Surface functionalization of PLGA nanoparticles to increase transport across the BBB for Alzheimer's disease L Del Amo, A Cano , M Ettcheto, EB Souto , M Espina - Applied sciences, 2021 - mdpi.comhttps://www.mdpi.com/2076-3417/11/9/4305 Polymeric nanoparticles as a vehicle for delivery of antioxidants in the brain: Potential application in neurodegenerative diseases JM Rabanel , G Djiokeng-Paka - Biomedical Application , 2017 - taylorfrancis.comhttps://www.taylorfrancis.com/chapters/edit/10.1201/9781315152363-12/polymeric-nanoparticles-vehicle-delivery-antioxidants-brain-jean-michel-rabanel-ghislain-djiokeng-paka-charles-ramassamy Nucleic-acid based Structures as Smart Nanotools in Neurotherapeutics JAV da Silva - 2016 - repositorio-aberto.up.pthttps://repositorio-aberto.up.pt/bitstream/10216/94251/2/157485.pdf Epigallocatechin-3-gallate (EGCG)-stabilized selenium nanoparticles coated with Tet-1 peptide to reduce amyloid-beta aggregation and cytotoxicity J Zhang, X Zhou, Q Yu, L Yang, D Sun - applied materials & , 2014 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/am501341u Conjugation, prodrug, and co-administration strategies in support of nanotechnologies to improve the therapeutic efficacy of phytochemicals in the central nervous G Rassu , M Sorrenti, L Catenacci, B Pavan , L Ferraro - Pharmaceutics, 2023 - mdpi.comhttps://www.mdpi.com/1999-4923/15/6/1578 Rational design of siRNA-based delivery systems for effective treatment of brain diseases D Lu, Y Sun, Y Luan, W He - Pharmaceutical Science Advances, 2024 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S2773216924000072 Tetanus toxin fragment C: structure, drug discovery research and production C Bayart , A Mularoni, N Hemmani , S Kerachni, J Jose - Pharmaceuticals, 2022 - mdpi.comhttps://www.mdpi.com/1424-8247/15/6/756 Overcoming barriers in non-viral gene delivery for neurological applications A Tasset, A Bellamkonda, W Wang , I Pyatnitskiy - Nanoscale, 2022 - pubs.rsc.orghttps://pubs.rsc.org/en/content/articlehtml/2022/nr/d1nr06939j Curcumin loaded-PLGA nanoparticles conjugated with Tet-1 peptide for potential use in Alzheimer's disease A Mathew, T Fukuda, Y Nagaoka, T Hasumura - PLoS one, 2012 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0032616

Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :

Propriétés chimiques

MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :

Informations sur les risques

Numéro ONU :
EQ:
Classe :
Phrases R :
Phrases S :
Transport aérien interdit :
Informations sur les risques :
Groupe d'emballage :
LQ :

Question d’ordre technique sur : 3D-PP46163 H-HLNILSTLWKYR-NH2

Veuillez plutôt utiliser le panier afin de demander un devis ou passer commande

Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages

* Champ obligatoire
Bienvenue chez CymitQuimica !Nous utilisons des cookies pour améliorer votre visite. Nous n’incluons pas de publicité.

Veuillez consulter notre Politique de Cookies pour plus de détails ou ajustez vos préférences dans "Configurer".